XTrend
MenuXTrend

Stock Charts

Charts can help you clearly see the market trend.

WBA

Walgreens Boots Alliance, Inc.

Bid11.17
Ask11.21
Change-0.04
% Chg -0.36%
High11.21
Low11.08

Past performance is not an indication of future results.

About

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Industry

Food & Drug Retailing

Stock Exchange

NASDAQ

Listing Date

31-12-2014

Trading Specifications
Minimum Price Fluctuation
--
Spreads as low as
--
Average Spreads
--
Minimum Lot Size
--
Commission
--
Trading Hours(GMT+2)
--
Maximum Trading Volume (lots)
--
News
Walgreens Expands Micro-Fulfillment Network with New Facility in Brooklyn Park, Minnesota
Walgreens Committed to Supporting Rite Aid Customers and Employees
Walgreens ends agreements, launches $2.5 billion A/R facility
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025
Walgreens to pay $300 million in settlement over U.S. opioid allegations
Walgreens settles opioid litigation for $300 million
Walgreens Boots Alliance beats Q2 expectations, shares edge higher
Walgreens Boots Alliance Reports Fiscal 2025 Second Quarter Results
Walgreens Boots earnings beat by $0.10, revenue topped estimates
XTrend

AFA REGIONAL SPONSOR

XTrendEnglish
XTrend
XTrend
XTrend
XTrend
XTrend